Is AbbVie Inc. the Best Pharma Dividend Stock to Buy In 2024?
| MUIGX Fund | USD 16.21 0.20 1.22% |
Slightly above 61% of Nationwide Growth's investor base is looking to short. The analysis of overall sentiment of trading Nationwide Growth Fund mutual fund suggests that many investors are alarmed at this time. Nationwide Growth's investing sentiment can be driven by a variety of factors including economic data, Nationwide Growth's earnings reports, geopolitical events, and overall market trends.
Nationwide |
We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where AbbVie Inc. stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower
Read at finance.yahoo.com
 |
Nationwide Growth Fundamental Analysis
We analyze Nationwide Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nationwide Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nationwide Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Nationwide Growth is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Nationwide Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nationwide Growth mutual fund to make a market-neutral strategy. Peer analysis of Nationwide Growth could also be used in its relative valuation, which is a method of valuing Nationwide Growth by comparing valuation metrics with similar companies.
Peers
Nationwide Growth Related Equities
| PBXIX | Rational/pier | 0.09 |
| ||
| ARBOX | Absolute Convertible | 0.09 |
| ||
| GCV | Gabelli Convertible | 0.52 |
| ||
| VICIX | Victory Incore | 0.67 |
| ||
| VAADX | Virtus Convertible | 0.97 |
|
Other Information on Investing in Nationwide Mutual Fund
Nationwide Growth financial ratios help investors to determine whether Nationwide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nationwide with respect to the benefits of owning Nationwide Growth security.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |